In this interview, Jessica L. Wenzel, MD, MPH, discusses key takeaways from the study, “Occupational Radiation Exposure During Pregnancy: A Survey of Urologists on Perception, Experience,...
In this interview, Kevin R. Basralian, MD, discusses the current state of focal therapy in prostate cancer in terms of the types of therapies and how...
In this video, Katherine Chan, MD, MPH, discusses risk factors for kidney stones in children. Chan is vice chair for research, director of the Pediatric Kidney...
In this interview, Briony K. Varda, MD, MPH, highlights the background and key findings from the study, “Antibiotic Overtreatment of Presumed Urinary Tract Infection Among Children...
The FDA has granted a fast track designation to SYNC-T SV-102, an investigational therapy for patients with metastatic castrate-resistant prostate cancer (mCRPC), according to a news...
In this interview, Jessica L. Wenzel, MD, MPH, shares the background and key findings from the study, “Occupational Radiation Exposure During Pregnancy: A Survey of Urologists...
In this video, Olivia H. Chang, MD, MPH, FACOG, discusses her KL2 award for studying the use of artificial intelligence for predicting neurogenic bladder treatment outcomes....
In this video, Joshua Linscott, MD, PhD, shares key findings from the study, “Tumor fraction and copy number burden from urinary cell-free tumor DNA (utDNA) to...
In this video, Jaleh Fallah, MD, discusses limitations of the Journal of the National Cancer Institute paper, “Cytoreductive nephrectomy in the era of immune checkpoint inhibitors:...
Defining prostate cancer contours with the artificial intelligence (AI)-powered mapping technology UnfoldAI reduced underestimation of the extent of prostate cancer compared with standard of care (SOC)...
In this video, Rohan Garje, MD, highlights the background, key findings, and implications based on the study, “Implications of HPV infection on survival outcomes in patients...
In this video, Viktor Grünwald, MD, PhD, highlights the background and key findings from the abstract, “Lenvatinib plus pembrolizumab (L+P) vs sunitinib (S) in advanced renal...